Spending shows, revenue follows: current results carry the cost of business whose payment is already scheduled to arrive
The model's full reasoning — Q2 2023 call → NOWe need to determine if management explains that the reported results are burdened by costs for specific business whose revenue/benefit has not yet arrived but is expected to begin arriving on a near-term, largely known schedule. The essence: current period absorbed costs of growth whose corresponding revenue is scheduled to follow. Look for management's own words. In the transcript, management discusses several items. Key points: - They mention the InnovAATe trial (Phase III) enrollment ramping, and they are investing in R&D and commercial activities. They say operating expenses will increase 15-20% in 2023 as they continue to invest in commercial activities and the Phase III trial. That is current spending for future potential revenue, but the revenue from that trial is far off (not near-term, and not secured). So that doesn't fit. - They mention the plasma collection center expansion: "We are successfully expanding the high premium plasma collection capacity at our first center, and we tend on opening our second collection center in Houston, Texas in early 2024." That is a cost now (expansion) for future revenue, but the revenue from that is not yet arrived, and it's not clear that it's "largely in hand" - it's a new center opening, but the revenue is not yet secured. Also, the timing is early 2024, which is within a year, but the revenue from that center is not yet won. Management doesn't explicitly say that the current period absorbed costs for that specific business with revenue scheduled to follow. - They mention the tech transfer of CYTOGAM to their Israeli facility. They got FDA approval and Health Canada approval. They expect to initiate sales of product manufactured in Israeli facility early in Q4 of this year. That is a cost incurred for tech transfer (presumably) and now they have approval, and sales will start soon. But does management say that the reported results are burdened by costs for that? They don't explicitly say that the current period's costs are for that. They mention the approval ensures continued supply, but they don't tie current costs to that. - They mention KEDRAB sales increase, but that's revenue already. - They mention the $60 million financing, but that's future. - They mention the U.S. team established during 2022 continues to promote products. That is ongoing investment, but not necessarily a timing mismatch.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| TSN | Tyson Foods, Inc. | Q2 2023 | 2023-05-08 | D |
| KE | Kimball Electronics, Inc. | Q3 2023 | 2023-05-06 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| RPM | RPM International Inc. | Q2 2017 | 2017-01-05 | D |
| TGI | Triumph Group, Inc. | Q2 2017 | 2016-11-03 | C+ |
| CHDN | Churchill Downs Incorporated | Q2 2016 | 2016-08-04 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
PUMP · Q4 2023 → YESThe question is about whether management explains that the results are burdened by costs already incurred for specific business whose revenue hasn't arrived yet but is expected soon. YES The transcript shows management explicitly linking the Q4 retention of crews and labor costs (despite lower utilization) to the fact that customers were starting back in early January, with the recovery already happening. It also ties the $4.3 million lease expense for FORCE electric fleets directly to the fleets already deployed and on contract 3–4 months earlier, noting that additional lease costs will begin blending in as fleets 3 and 4 deploy in the coming months—while those same fleets are already under contract and expected to generate revenue soon. This creates the described timing mismatch: current-period costs for identified, secured business whose revenue side is scheduled to arrive on a near-term, known schedule. The Q&A confirms the costs are already being incurred for the upcoming activity rather than for uncommitted or aspirational growth. No other factors (inflation, weak demand, etc.) are cited as the primary driver.
GOGO · Q1 2016 → YESThe question is about whether management explains that current results are burdened by costs already being incurred for specific business whose revenue hasn't arrived yet but is expected soon. NO The transcript attributes the higher rest-of-world segment loss to “higher ED&D expenses related to 2Ku STC and line fit activities” for the 600+ awarded aircraft that are still not installed. While those costs are real and already being incurred, the revenue side is described as “install the majority … by 2018,” which is more than a year out and not framed as “near-term” or “largely known schedule” within the coming year. Management does not present the current-period spending as the expense side of commitments whose income is already scheduled to arrive soon; instead, the timeline is explicitly longer.
CHDN · Q2 2016 → YESThe question is about whether management explains that the results are burdened by costs already incurred for specific business whose revenue hasn't arrived yet but is expected soon. YES The transcript shows clear management explanation of this exact timing mismatch. For Big Fish, Bill Carstanjen directly states that UA expense is recognized immediately while revenue from those users is realized over months or years, and they are investing in specific games (Gummy Drop!, Sunken Secret, Cascade, Fairway Solitaire 1 & 2, Dungeon Boss) to scale newer products.